![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
ER Korpi, T Kuner, PH Seeburg and H Luddens
Biomedical Research Center, Alko Ltd., Helsinki, Finland.
Numerous ligands affect inhibitory gamma-aminobutyric acid (GABA)A receptors, none of them showing strict receptor subtype specificity. We report here that a cerebellar GABAA receptor subtype can be uniquely modulated by furosemide but not by bumetanide, another Cl-/cation transport blocker. Furosemide specifically reversed the inhibition by GABA of t-[35S]butylbicyclophosphorothionate ([35S]TBPS) binding in the cerebellar granule cell layer, as detected by autoradiography of rat brain sections. With recombinant receptors expressed in Xenopus oocytes, furosemide antagonized potently (IC50, about 10 microM), rapidly, and reversibly GABA-evoked currents of cerebellar granule cell- specific alpha 6 beta 2 gamma 2 receptors but not alpha 1 beta 2 gamma 2 receptors (IC50, > 3 mM). Furosemide reversed GABA inhibition of [35S]TBPS binding and elevated basal [35S]TBPS binding only with alpha 6 beta 2 gamma 2 and alpha 6 beta 3 gamma 2 receptors and not with alpha 6 beta 1 gamma 2 or alpha 1 beta 1/2/3 gamma 2 receptors. It appeared to interact with the receptor complex via a novel recognition site that allosterically regulates the Cl- ionophore. Furosemide is the first subtype-selective GABAA receptor (alpha 6 beta 2/3 gamma 2) antagonist and should facilitate studies on cerebellar physiology. It might serve as a prototypic structure for the development of additional subtype-selective GABAA ligands.
This article has been cited by other articles:
|
|
 |
|
  W. Hevers, S. H. Hadley, H. Luddens, and J. Amin Ketamine, But Not Phencyclidine, Selectively Modulates Cerebellar GABAA Receptors Containing {alpha}6 and {delta} Subunits J. Neurosci., May 14, 2008; 28(20): 5383 - 5393. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. J. Herden, N. E. Pardo, R. K. Hajela, Y. Yuan, and W. D. Atchison Differential Effects of Methylmercury on {gamma}-Aminobutyric Acid Type A Receptor Currents in Rat Cerebellar Granule and Cerebral Cortical Neurons in Culture J. Pharmacol. Exp. Ther., February 1, 2008; 324(2): 517 - 528. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. L. Payne, W. M. Connelly, J. H. Ives, R. Lehner, B. Furtmuller, W. Sieghart, P. Tiwari, J. M. Lucocq, G. Lees, and C. L. Thompson GABAA {alpha}6-Containing Receptors Are Selectively Compromised in Cerebellar Granule Cells of the Ataxic Mouse, Stargazer J. Biol. Chem., October 5, 2007; 282(40): 29130 - 29143. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. H. Hadley and J. Amin Rat {alpha}6beta2{delta} GABAA receptors exhibit two distinct and separable agonist affinities J. Physiol., June 15, 2007; 581(3): 1001 - 1018. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Lisk, M. Kang, J. V. Cohn, and S. A. Desai Specific Inhibition of the Plasmodial Surface Anion Channel by Dantrolene Eukaryot. Cell, November 1, 2006; 5(11): 1882 - 1893. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Santhakumar, H. J. Hanchar, M. Wallner, R. W. Olsen, and T. S. Otis Contributions of the GABAA receptor alpha6 subunit to phasic and tonic inhibition revealed by a naturally occurring polymorphism in the alpha6 gene. J. Neurosci., March 22, 2006; 26(12): 3357 - 3364. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Alkhalil, J. V. Cohn, M. A. Wagner, J. S. Cabrera, T. Rajapandi, and S. A. Desai Plasmodium falciparum likely encodes the principal anion channel on infected human erythrocytes Blood, December 15, 2004; 104(13): 4279 - 4286. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. I. Ortinski, C. Lu, K. Takagaki, Z. Fu, and S. Vicini Expression of Distinct {alpha} Subunits of GABAA Receptor Regulates Inhibitory Synaptic Strength J Neurophysiol, September 1, 2004; 92(3): 1718 - 1727. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Minier and E. Sigel Positioning of the {alpha}-subunit isoforms confers a functional signature to {gamma}-aminobutyric acid type A receptors PNAS, May 18, 2004; 101(20): 7769 - 7774. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. T. Sinkkonen, S. Mansikkamaki, T. Moykkynen, H. Luddens, M. Uusi-Oukari, and E. R. Korpi Receptor Subtype-Dependent Positive and Negative Modulation of GABAA Receptor Function by Niflumic Acid, a Nonsteroidal Anti-Inflammatory Drug Mol. Pharmacol., September 1, 2003; 64(3): 753 - 763. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. C. Engblom, F. F. Johansen, and U. Kristiansen Actions and Interactions of Extracellular Potassium and Kainate on Expression of 13 gamma -Aminobutyric Acid Type A Receptor Subunits in Cultured Mouse Cerebellar Granule Neurons J. Biol. Chem., May 2, 2003; 278(19): 16543 - 16550. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. K. Hoffpauir and E. L. Gleason Activation of mGluR5 Modulates GABAA Receptor Function in Retinal Amacrine Cells J Neurophysiol, October 1, 2002; 88(4): 1766 - 1776. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Fisher Amiloride Inhibition of gamma -Aminobutyric AcidA Receptors Depends upon the alpha Subunit Subtype Mol. Pharmacol., June 1, 2002; 61(6): 1322 - 1328. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Louiset, R. McKernan, W. Sieghart, and H. Vaudry Subunit Composition and Pharmacological Characterization of {gamma}-Aminobutyric Acid Type A Receptors in Frog Pituitary Melanotrophs Endocrinology, March 1, 2000; 141(3): 1083 - 1092. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.A. Thompson, S.A. Arden, G. Marshall, P.B. Wingrove, P.J. Whiting, and K.A. Wafford Residues in Transmembrane Domains I and II Determine gamma -Aminobutyric Acid Type AA Receptor Subtype-Selective Antagonism by Furosemide Mol. Pharmacol., June 1, 1999; 55(6): 993 - 999. [Abstract] [Full Text]
|
|
|
|
|
|
T. R. Neelands, L. J. Greenfield Jr, J. Zhang, R. S. Turner, and R. L. Macdonald GABAA Receptor Pharmacology and Subtype mRNA Expression in Human Neuronal NT2-N Cells J. Neurosci., July 1, 1998; 18(13): 4993 - 5007. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. A. Barnard, P. Skolnick, R. W. Olsen, H. Mohler, W. Sieghart, G. Biggio, C. Braestrup, A. N. Bateson, and S. Z. Langer International Union of Pharmacology. XV. Subtypes of gamma -Aminobutyric AcidA Receptors: Classification on the Basis of Subunit Structure and Receptor Function Pharmacol. Rev., June 1, 1998; 50(2): 291 - 314. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Fisher, J. Zhang, and R. L. Macdonald The Role of alpha 1 and alpha 6 Subtype Amino-Terminal Domains in Allosteric Regulation of gamma -Aminobutyric Acida Receptors Mol. Pharmacol., October 1, 1997; 52(4): 714 - 724. [Abstract] [Full Text]
|
|
|
|
|
|
R. Mäkelä, M. Uusi-Oukari, G. E. Homanics, J. J. Quinlan, L. L. Firestone, W. Wisden, and E. R. Korpi Cerebellar gamma -Aminobutyric Acid Type A Receptors: Pharmacological Subtypes Revealed by Mutant Mouse Lines Mol. Pharmacol., September 1, 1997; 52(3): 380 - 388. [Abstract] [Full Text]
|
|
|
|
|
|
A. Jones, E. R. Korpi, R. M. McKernan, R. Pelz, Z. Nusser, R. Makela, J. R. Mellor, S. Pollard, S. Bahn, F. A. Stephenson, et al. Ligand-Gated Ion Channel Subunit Partnerships: GABAA Receptor alpha 6 Subunit Gene Inactivation Inhibits delta Subunit Expression J. Neurosci., February 15, 1997; 17(4): 1350 - 1362. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Tia, J. F. Wang, N. Kotchabhakdi, and S. Vicini Developmental Changes of Inhibitory Synaptic Currents in Cerebellar Granule Neurons: Role of GABAA Receptor alpha 6 Subunit J. Neurosci., June 1, 1996; 16(11): 3630 - 3640. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
